Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2017-05-19 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is very short (1176 characters) and contains an 'RNS Number' header, indicating it is a regulatory announcement from the London Stock Exchange's RNS service. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific market operational notice. Since this does not fit neatly into the defined categories like Earnings Release (ER), Annual Report (10-K), or Director's Dealing (DIRS), and it is a general regulatory announcement, the most appropriate fallback category is Regulatory Filings (RNS).
2017-05-19 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1159 characters) and explicitly states it is an 'RNS Number' notification from the London Stock Exchange. The content describes a 'Price Monitoring Extension' for an auction call period, which is a specific, short-form operational announcement related to trading mechanics, not a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, DIV, or ER, the most appropriate classification is the general regulatory filing fallback category, RNS.
2017-05-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 4093F' and contains the header 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This format is standard for notifications regarding changes in major shareholdings, which corresponds to the Major Shareholding Notification category (MRQ). Although RNS is present, MRQ is the more specific classification for this type of regulatory filing concerning ownership thresholds.
2017-05-17 English
Trading Update
Earnings Release Classification · 92% confidence The document is a 'Trading update' from Provexis plc, dated May 10, 2017, referencing the financial year ended March 31, 2017. It provides preliminary financial figures (£228k revenue, £382k operating loss) and discusses ongoing commercial activities, R&D collaborations (DSM, BY-HEALTH), and scientific studies. This content is characteristic of an announcement detailing recent operational and financial performance before the full annual report (10-K) or interim report (IR) is released, as it explicitly states the preliminary results statement is 'currently scheduled for early September'. Since it provides key financial highlights and operational updates outside of a formal quarterly/annual report structure, it fits best as an Earnings Release (ER) or a general regulatory announcement. Given the nature of providing key financial metrics and operational progress updates, 'ER' (Earnings Release) is the most appropriate fit, even though it's a trading update rather than a formal earnings release, as it precedes the full results. However, since it is explicitly labeled 'RNS Number' and contains a mix of operational updates, partnership news, and preliminary financial expectations, it also strongly aligns with a general regulatory announcement. Given the specific definitions, 'ER' covers the financial update aspect, but 'RNS' covers the format and general nature of providing timely, non-standardized operational news. Since it contains specific financial expectations for the year end, ER is slightly more precise than the general RNS fallback, but the document structure (RNS Number) suggests a broad regulatory filing. Given the content is a 'Trading update' providing key financial metrics ahead of the formal results, it functions as an early earnings communication. I will classify it as ER, but acknowledge the RNS format. FY 2017
2017-05-10 English
Results of Placing
Capital/Financing Update Classification · 98% confidence The document is an official announcement from Provexis PLC, identified by the 'RNS Number' header and the closing 'This information is provided by RNS' statement. The content details the successful completion of a share placing ('Results of placing') to raise gross £350,000 by issuing new ordinary shares. This action directly relates to fundraising, capital structure changes, and the issuance of new shares. This fits best under 'Capital/Financing Update' (CAP) as it is a specific announcement about raising capital through a share placement. While it involves shares, it is primarily a financing event rather than a general share repurchase (POS) or a general regulatory filing (RNS). Since it is a specific announcement about capital raising, CAP is the most precise fit.
2017-05-10 English
Funding Update
Capital/Financing Update Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details an announcement titled 'Funding Update' regarding two planned equity subscriptions (£170,000 + £30,000 indications for the first, and £370,000 indications for the second, contingent on EIS clearance). This is a specific corporate action announcement related to financing and capital structure, not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS) if a more specific category fits. The core subject is raising working capital through share subscriptions, which aligns best with the 'Capital/Financing Update' category (CAP). Although it is distributed via RNS, the specific nature of the content dictates the CAP classification over the general RNS fallback.
2017-05-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.